INO:NASDAQ
Inovio Pharmaceuticals Inc
1,71Â US$
arrow_upward
+1,18%(+0,020) 1K
1,70Â US$
arrow_downward
-0,72% (-0,012)bedtimeYopilgandan keyin
Savdolar yopilgan: 19-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINO tikeri uchun statistika yaratilmoqda...
Ochish
1,72Â US$
Yuqori
1,79Â US$
Past
1,63Â US$
Bozor kapitali
320,29Â mln
Oʻrtacha hajm
20,21Â mln
Hajmi
9,94Â mln
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,57Â US$
Aksiya boʻyicha daromad
-0,80Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Ochish
1,72Â US$
Yuqori
1,79Â US$
Past
1,63Â US$
Bozor kapitali
320,29Â mln
Oʻrtacha hajm
20,21Â mln
Hajmi
9,94Â mln
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,57Â US$
Aksiya boʻyicha daromad
-0,80Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com
·
1 kun oldin
Inovio at Jefferies Global Healthcare Conference: launch begins
News Corp
·
1 kun oldin
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Investing.com
·
1 kun oldin
Inovio submits European approval application for RRP treatment
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals Inc haqida
CEOJacqueline Shea
Xodimlar soni112
Asos solingan1999
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytinovio.com